MEETINGS - Workshop on Central-East European Countries and European Community: IVD (in vitro diagnostic) Directive 98/79/EC and Central-East European Countries Regulations (Czech Republic) September 2002:
This article was originally published in Clinica
Executive Summary
The European Diagnostics Manufacturers Association (EDMA) is hosting a workshop on Central-East European Countries and European Community: IVD Directive 98/79/EC and Central-East European Countries Regulations on September 24 2002 at the Hotel Pyramida, Prague, Czech Republic. Workshop highlights include the EDMA Central Europe Working Party and its activities, details on Switzerland adopting the CE mark, industry and competent authority perspectives of the IVD Directive, and CEEC regulations and future prospects. Further details from EDMA, on tel: +32 2772 2225; fax: +32 2772 2329; email: [email protected] www.edma.ivd.be
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.